Can Artificially Designed Protein Combat Cancer?
For a long time, cancer-therapeutic drugs are made to targetvarious DDR components present especially in cancerous cells [7].But let’s think the other way round can we utilize the high frequency of Replication-Transcription collision in cancerous cells and design a certain protein that can identify the collision sites and bindto and fuse both Transcription-Replication types of machinery, toirreversibly cause Replication Fork Stalling, the precancerous andcancerous cells will eventually get degraded as their genome willnot replicate. The question here is If a protein can be devised, ableto detect the collision sites and fuse the two types of machineryirreversibly, can division and metastasis of pre-/cancerous be prevented?At the onset of collision, the cell synthesizes Fob1 protein tobind to the DNA sequence, present in between the soon-to-collideReplication-Transcription machinery, known as Replication ForkBarrier (RFB) site, to prevent a collision [8]. The Fob1 protein’sgene sequence can be procured and can be used to incorporate ourdesigner protein sequence in place of the Fob1 gene, using Group 2Intron mediated gene replacement. so that whenever the cell generates the Fob1 synthesis signal, our Protein-X will be synthesizedin place of Fob1. Using Bioinformatics tools, Protein-X should bedesigned in such a way, that it must have 2 specific domains to bindto the RNA polymerase and the DNA polymerases (like NtrC and other transcriptional factors), and form a bridge-like bond in between them, that is permanent. By this, the two colliding machineries will fuse, causing multiple irreversible fork stalls throughoutthe genome at the collision sites, ultimately causing failure in genome duplication. And thereby, cancer-prone cells will eventuallydegrade